ESC 365 - Glucagon-like peptide-1 receptor agonists and changing paradigms in clinical practice.

Open Access

Glucagon-like peptide-1 receptor agonists and changing paradigms in clinical practice.

Session: Discussion: Glucagon-like peptide-1 receptor agonists and changing paradigms in clinical practice

Topic: Diabetes and the Heart

Speaker: Doctor B. Scirica (Boston, US)

Sponsored by Novo Nordisk A/S

Event: ESC Congress 2018

Congress Presentation

About the speaker

Doctor Benjamin Morgan Scirica

Brigham and Women's Hospital, Boston (United States of America)

8 presentations

0 follower

3 more presentations in this session

New insights into glucagon-like peptide-1 receptor agonist treatment considerations.

Speaker: Professor S. Verma (Toronto, CA)

Clinical aspects: type 2 diabetes, cardiovascular disease and glucagon-like peptide-1 receptor agonists.

Speaker: Professor M. Pfeffer (Boston, US)

Perspective on glucagon-like peptide-1 receptor agonists in type 2 diabetes and cardiovascular disease: Interactive discussion.

Speaker: Doctor B. Scirica (Boston, US) Professor S. Verma (Toronto, CA) Professor M. Pfeffer (Boston, US)

Access the full session

Discussion: Glucagon-like peptide-1 receptor agonists and changing paradigms in clinical practice

Speakers: Doctor B. Scirica, Professor S. Verma, Professor M. Pfeffer, Doctor B. Scirica, Professor S. Verma...

About the event

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by